JPRN-jRCTs031180043已完成4 期
Investigation of the effect of empagliflozin on cardiac sympathetic and parasympathetic nerve activity in Japanese patients with type 2 diabetes (EMPYREAN) - EMPYREA
Kuwahara Kouichiro0 个研究点目标入组 113 人开始时间: 2018年11月27日最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 113
研究概览
简要总结
Effects of empagliflozin and sitagliptin on autonomic nerve activities were not significantly different in patients with type 2 DM.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 < 75age old（—）
- 性别
- All
入选标准
- •Type 2 DM (HbA1c 6.5-10%) . HbA1c 7.0-10% for patients who are taking sulfonylurea/glinides.
排除标准
- •Treated with Insulin, GLP-1 analogue, SGLT2/DPP4 inhibitors
研究者
相似试验
招募中
4 期
A study examining the effects of empagliflozin (Jardiance®), a tablet for treatment of diabetes on autonomic nervous system and heart function in patients with type 2 diabetes.Metabolic and Endocrine - DiabetesCardiovascular - Normal development and function of the cardiovascular systemType 2 DiabetesACTRN12619000887178Baker Heart and Diabetes Institute60
尚未招募
2 期
Comparing the effect of Empagliflozin, Pioglitazone and their combination, on the course of non-alcoholic fatty liver disease in diabetic patientson-alcoholic fatty liver disease.Fatty (change of) liver, not elsewhere classifiedK76.0IRCT20230903059343N1Arak University of Medical Sciences120
尚未招募
2 期
Assessment of extra-renal effects of SGLT2-inhibitors in anuric haemodialysis patients using microneurographyACTRN12623001237673Dobney Hypertension Centre20
已完成
不适用
Investigation of the effect of empagliflozin on cardiac sympathetic and parasympathetic nerve activity in Japanese patients with type 2 diabetesDiabetes Mellitus (type 2)JPRN-UMIN000029194Shinshu University School of Medicine112
已完成
3 期
Effects of empagliflozin in diabetes treatmentIRCT20191126045505N1Bojnourd University of Medical Sciences100